Ectopic atrial tachycardia (EAT) is a type of heart arrhythmia that is characterized by a rapid heartbeat. It is caused by an abnormal electrical signal that originates in the atria, the upper chambers of the heart. This signal causes the heart to beat faster than normal, resulting in a rapid, irregular heart rate. EAT can be very dangerous and can lead to serious complications, such as stroke, heart failure, and even death. In this article, we will take a look at EAT, its causes, symptoms, diagnosis, and treatment.
The exact cause of EAT is unknown, but it is thought to be related to an abnormality in the electrical conduction system of the heart. It is believed that the abnormal electrical signal originates in the atria and then travels to the ventricles, the lower chambers of the heart. This causes the ventricles to beat faster than normal, resulting in a rapid, irregular heart rate. EAT can be caused by a variety of factors, including structural heart defects, medications, and electrolyte imbalances. Structural heart defects, such as a congenital heart defect, can cause the electrical conduction system to malfunction, resulting in EAT. Medications, such as certain antiarrhythmic drugs, can also trigger EAT. Finally, electrolyte imbalances, such as an abnormally low level of potassium, can also cause EAT.
The most common symptom of EAT is a rapid, irregular heartbeat. Patients may also experience lightheadedness, dizziness, shortness of breath, chest pain, and fatigue. In some cases, the symptoms may be so severe that they require immediate medical attention.
EAT is usually diagnosed with an electrocardiogram (ECG). An ECG is a test that records the electrical activity of the heart. It can help doctors identify the abnormal electrical signal that causes EAT. Other tests, such as an echocardiogram, can also be used to diagnose EAT.
The treatment for EAT depends on the underlying cause. If the cause is a structural heart defect, surgery may be necessary to repair the defect. If the cause is a medication, the doctor may recommend stopping the medication or switching to a different one. If the cause is an electrolyte imbalance, the doctor may recommend dietary changes or medications to correct the imbalance. In some cases, medications may be used to slow the heart rate and prevent the arrhythmia from occurring. These medications include beta blockers, calcium channel blockers, and antiarrhythmic drugs. In severe cases, a pacemaker may be implanted to regulate the heart rate.
Ectopic atrial tachycardia is a type of heart arrhythmia that is characterized by a rapid, irregular heartbeat. It is caused by an abnormal electrical signal originating in the atria, the upper chambers of the heart. EAT can be very dangerous and can lead to serious complications, such as stroke, heart failure, and even death. The exact cause of EAT is unknown, but it is thought to be related to an abnormality in the electrical conduction system of the heart. The most common symptom of EAT is a rapid, irregular heartbeat. EAT is usually diagnosed with an electrocardiogram (ECG). The treatment for EAT depends on the underlying cause and may include medications, surgery, dietary changes, or the implantation of a pacemaker.
1.
In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?
2.
Report reveals lung cancer is the leading cause of cancer deaths in Florida
3.
FDA Expands Approval of Osimertinib in Lung Cancer
4.
Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk
5.
Venetoclax Combo Shows Promise in Younger Patients With AML
1.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
2.
Biomimetic Nanovesicles Target Senescent-Escape Cancer Stem Cells in Breast Cancer
3.
Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
Tumor Microenvironment Readiness as a Predictor of Cancer Progression
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
Chemotherapy: What to Expect
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation